TELA Bio (TELA) Change in Account Payables (2018 - 2026)
TELA Bio (TELA) posted quarterly Change in Account Payables of $1.6 million for Q1 2026, down 14.03% year-over-year from $1.9 million in Q1 2025, and up 2628.57% quarter-over-quarter from -$63000.0 in Q4 2025.
TELA Bio (TELA) Change in Account Payables (2018 - 2026) Analysis & Trends
TELA Bio's Change in Account Payables history runs 9 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 14.03% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at -$119000.0 (down 114.51% YoY), while the FY2025 annual figure was $141000.0, down 70.75% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.6 million, up from -$63000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $3.7 million in Q1 2023, with the low at -$3.7 million in Q2 2022.
- The 5-year median for Change in Account Payables is $42000.0 (2024), against an average of $79000.0.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables tumbled 28963.64% in 2022, then jumped 1452.38% in 2025.
- TELA Bio's Change in Account Payables stood at -$3.2 million in 2022, then surged by 52.0% to -$1.5 million in 2023, then jumped by 89.9% to -$154000.0 in 2024, then surged by 59.09% to -$63000.0 in 2025, then soared by 2628.57% to $1.6 million in 2026.
- Business Quant data shows TELA's Change in Account Payables at $1.6 million in Q1 2026, -$63000.0 in Q4 2025, and $652000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 4.30 Mn |
| 10 | TELA Bio | 36.75 Mn | 6.32 Mn | 13.94 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 Mn |
| Jun 30, 2026 | -1.01 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | 652,000.00 |
| Sep 30, 2025 | 652,000.00 |
| Jun 30, 2025 | -2.30 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | -154,000.00 |
| Dec 31, 2024 | -154,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | -921,000.00 |
| Jun 30, 2024 | -921,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |